On 11/8/23, Catalyst Biosciences Inc (NASDAQ: CBIO) stock enjoyed a major increase of 14.3%, closing at $9.20. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 36.7% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, CBIO is expected to be a major Value Eraser.
Catalyst Biosciences is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment